1) 秋山一文,小杉真一,室井秀太,他:抗精神病薬による遅発性錐体外路症状治療のアルゴリズム.林田雅希,佐藤光源,樋口輝彦,編,統合失調症の薬物治療アルゴリズム.医学書院,pp73-93,2006
2) Chiu HF, Lam LC, Chan CH, et al:Clinical and polygraphic characteristics of patients with respiratory dyskinesia. Br J Psychiatry 162:828-830, 1993
3) Correll CU, Leucht S, Kane JM:Lower risk for tardive dyskinesia associated with second-generation antipsychotics:A systematic review of 1-year studies. Am J Psychiatry 161:414-425, 2004
4) Hayashi T, Nishikawa T, Koga I, et al:Prevalence of and risk factors for respiratory dyskinesia. Clin Neuropharmacol 19:390-398, 1996
5) Jeste DV, Caligiuri MP, Paulsen JS, et al:Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients. Arch Gen Psychiatry 52:756-765, 1995
6) Oosthuizen PP, Emsley RA, Maritz JA, et al:Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol. J Clin Psychiatry 64:1075-1080, 2003
7) Rich MW, Radwany SM:Respiratory dyskinesia:An underrecognized phenomenon. Chest 105:1826-1832, 1994
8) Richardson MA, Bevans ML, Read LL, et al:Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men. Am J Psychiatry 160:1117-1124, 2003
9) Sweet RA, Mulsant BH, Gupta B, et al:Duration of neuroleptic treatment and prevalence of tardive dyskinesia in late life. Arch Gen Psychiatry 52:478-486, 1995
10) Yassa R, Lal S:Respiratory irregularity and tardive dyskinesia:A prevalence study. Acta Psychiatr Scand 73:506-510, 1986